×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Drug Development and the Virtual Company
Session Chair(s)
Carrie Nodgaard Helland, MBA, PMP
Vice President, Project Management and Manufacturing
CytRx Corporation, United States
This forum will explore drug development at the virtual biotechnology company through cash planning, management, and control for development programs; the role of the project manager; and partnering and outsourcing.
Learning Objective : Demonstrate techniques for managing global drug development at a small, virtual company in the areas of cash management, project management and outsourcing; Discuss techniques to budget and forecast with limited cash flow, for virtual team management; Describe strategies for structuring outsourcing contracts in order to minimize risk to capital.
Speaker(s)
Drug Development and the Virtual Company: Project Management
Haley Laken, PhD
Tesaro, United States
Director
Drug Development and the Virtual Company: Outsourcing
Anca Maria Copaescu, MBA, MSc
BioMarin Pharmaceutical Inc., United States
Senior Director, Clinical Outsourcing and Analytics
Drug Development and the Virtual Company: Cash Management
Carrie Nodgaard Helland, MBA, PMP
CytRx Corporation, United States
Vice President, Project Management and Manufacturing
Have an account?